| Biomarker ID | 582 |
| PMID | 21237555 |
| Year | 2011 |
| Biomarker | GSTP1, BCL2, ADCY4, CACNA1G, LOC63928, and D4S234E |
| Biomarker Basis | Expression Based |
| Biomolecule | mRNA |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Downregulated |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Tumour Necrosis Factor alpha (TNF alpha) |
| Experiment | Tumor Vs Tumor Adjacent |
| Type of Biomarker | Diagnostic |
| Cohort | 17 patients with PCA tumors were analysed in the study. GEO Accession: GSE26319 |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.05 |
| Method Used | rt-PCR |
| Clinical | No |
| Remarks | For Expression based analysis, 17 pairs that were used, 12 overlapped with methylation analysis patients |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | GSTP1, BCL2, ADCY4, CACNA1G, NSG1 |